Marc E. Lippman, Director at SEATTLE GENETICS INC /WA (SGEN), sold 3,000 shares at $58.07 ($174K) on 2017-11-15, disclosed to the SEC on 2017-11-17.
Open-market sale of $174k SGEN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| SGEN | SELL | 2019-11-20 | $6.1M | — | Filing → |
| SGEN | SELL | 2018-08-02 | $512K | — | Filing → |
| SGEN | SELL | 2016-11-09 | $58K | — | Filing → |